The US Food and Drug Administration (FDA) has issued a Class I recall for the t:connect mobile app on iOS, which is used to monitor and control the t:slim X2 insulin pump used by people with diabetes. It was supposedly the first smartphone app that can program insulin doses that the FDA had approved. The agency issued the highest level of recall it could, because the app had serious software problems that could've have caused life-threatening conditions or even death. In fact, while there were... Read this story